RNS Number : 8333B

Biome Technologies PLC

12 October 2020

12 October 2020

Biome Technologies plc

("Biome", "the Company" or "the Group")

Result of General Meeting

Total Voting Rights

Biome announces that at the General Meeting of the Company held earlier today, all resolutions were passed. The proxy votes received from shareholders on each resolution are set out below.

  Resolutions                  Votes for*   %      Votes against   %     Votes            Votes 
                                                                          total       withheld* 
 1. To grant authority 
  to directors to allot 
  shares pursuant to 
  the Fundraise                1,080,103    98.6   15,653          1.4   1,095,756          354 
 2. To disapply pre-emption 
  rights in relation 
  to shares issued 
  pursuant to the Fundraise    1,080,457    98.6   15,653          1.4   1,096,110            0 
 3. To grant authority 
  to directors to allot 
  shares equivalent 
  to up to nominal 
  value of up to one 
  third of the Company's 
  Enlarged Share Capital       610,783      97.1   17,954          2.9   628,737        467,373 
 4. To disapply pre-emption 
  rights in relation 
  to the allotment 
  of shares equivalent 
  to 10% of the Company's 
  Enlarged Share Capital       612,730      97.4   16,007          2.6   628,737        467,373 

*Includes those votes giving the Chairman discretion

**A vote "withheld" is not a vote in law and is not counted towards the votes cast "for" or "against" a resolution

Following shareholder approval at the General Meeting, the 618,003 Second Placing Shares are expected to be admitted to trading on AIM on 14 October 2020. Further details on the Second Placing Shares and the Fundraise are contained within the Company's announcement of 24 September 2020.

Admission and Total Voting Rights

Application has been made for 618,003 new ordinary shares in the Company ("New Ordinary Shares"), which will rank pari passu with the existing ordinary shares in the Company, to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on 14 October 2020, following which the total number of ordinary shares and voting rights in the Company will be 3,673,525 .

The figure of 3,673,525 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company pursuant to the FCA's Disclosure Guidance and Transparency Rules.

Director Shareholdings

Paul Mines, Chief Executive Officer, and John Standen, Non-Executive Chairman of the Company, subscribed for 12,500 Ordinary Shares each in the Second Placing. Following Admission, Paul Mines will hold 44,025 Ordinary Shares, representing approximately 1.20 per cent. of the Company's issued ordinary share capital on Admission. Following Admission, John Standen will have a beneficial interest in 70,836 Ordinary Shares, representing approximately 1.93 per cent. of the Company's issued ordinary share capital on Admission.

Capitalised terms used but not defined in this announcement shall have the meanings given to such terms in the announcement issued by the Company dated 24 September 2020 unless otherwise defined herein.

For further information please contact:

Biome Technologies plc

Paul Mines, Chief Executive Officer

Donna Simpson-Strange, Company Secretary


Tel: +44 (0) 2380 867 100


Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Equity Sales)

Tel: +44 (0) 20 3328 5656


About Biome

Biome Technologies plc is an AIM quoted, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where value-added pricing can be justified and that are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited.

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers.

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.


   www.biomebioplastics.com         and      www.thinkbioplastic.com 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

October 12, 2020 11:07 ET (15:07 GMT)